Restriction of the PI3K/Akt pathway is beneficial to promote the differentiation of Treg and suppress the differentiation of Th1 and CD8+ T cells, thereby attenuating the inflammation response in metabolic diseases. This evidence concerns the gene CD8A and Other metabolic disease.